This retrospective cross-sectional analysis of caregiver-reported data from the PATRE Registry included 337 patients with SYNGAP1-related developmental and epileptic encephalopathy. The study examined associations between seizure semiology, peak seizure frequency, and caregiver-reported autistic behavior scores on a 1-5 Likert scale.
Atypical absences showed the most profound and statistically robust association with higher autistic behavior scores (n=77 patients; FDR-adjusted p=0.001). Significant positive associations were also found for typical absences (n=70; p=0.018), eyelid myoclonia (n=168; p=0.018), myoclonic-atonic seizures (n=40; p=0.019), and atonic seizures (n=72; p=0.025). Weaker associations were noted for focal seizures (p=0.026) and tonic-clonic seizures (p=0.047).
No significant correlation was detected between peak seizure frequency ratings and autistic behavior scores across all semiologies (e.g., eyelid myoclonia: p=0.096; atypical absences: p=0.744). Safety data were not reported.
Key limitations include the retrospective design, reliance on caregiver-reported data, and analysis restricted to participants with complete data (N=337 from total N=522). The observational nature precludes causal inference.
Clinically, atypical absences and related semiologies may serve as red flags for increased neurodevelopmental comorbidity severity, regardless of reported peak seizure frequency, though certainty is limited by the study design.
View Original Abstract ↓
Purpose SYNGAP1-related developmental and epileptic encephalopathy (SYNGAP1-DEE) is characterized by high rates of both epilepsy and autism spectrum disorder (ASD). While the clinical spectrum is well-documented, the link between specific seizure semiologies and caregiver-reported autistic behaviors is not well understood. This study analyzed the correlation between ten distinct seizure types, their frequencies, and a caregiver-reported autistic behavior score. Method Clinical data were extracted from the PATRE (PATient-based phenotyping and evaluation of therapy for Rare Epilepsies) Registry for SYNGAP1, in the framework of the EURAS project (Grant No. 101080580, Horizon Europe). This study employed a retrospective cross-sectional analysis of caregiver-reported registry data. Analysis was restricted to an analytic cohort of N=337 participants with complete data for both the epilepsy questionnaire (including epilepsy status, seizure semiology, and peak seizure frequency items) and the behavior questionnaire (from a total N=522 registry participants). Caregiver-reported autistic behaviors were quantified using a standardized caregiver-reported scale (Likert 1-5). Statistical associations were evaluated using the Wilcoxon rank-sum test to compare caregiver-reported autistic behavior scores across different seizure semiologies and Spearman's rank correlation to assess the impact of seizure frequency (9-point scale). Results Within the analytic cohort (N=337), epilepsy was reported in 259 patients. Eyelid myoclonia was the most prevalent semiology, affecting 64.9% (n=168) of the epilepsy-positive group. Atypical absences (n=77) demonstrated the most profound and statistically robust association with higher caregiver-reported autistic behavior scores (FDR-adjusted p = 0.001). Significant associations were also observed for typical absences (n=70, FDR-adjusted p = 0.018), eyelid myoclonia (FDR-adjusted p = 0.018), myoclonic-atonic seizures (n=40, FDR-adjusted p = 0.019), and atonic seizures (n=72, FDR-adjusted p = 0.025). Focal and tonic-clonic seizures showed weaker associations (FDR-adjusted p = 0.026 and p = 0.047, respectively). Crucially, quantitative analysis revealed no significant correlation between ordinal caregiver-reported peak seizure frequency ratings and caregiver-reported autistic behavior scores across all semiologies (e.g., Eyelid Myoclonia: p=0.096; Atypical Absences: p=0.744), indicating no detectable association between peak-frequency ratings and caregiver-reported autistic behavior scores. Conclusion Higher caregiver-reported autistic behavior scores in SYNGAP1-DEE were most strongly associated with the presence of atypical absences, representing a generalized, thalamocortical seizure network dysfunction. In contrast, no detectable association was observed between caregiver-reported autistic behavior scores and the ordinal caregiver-reported peak seizure frequency metric. Atypical absences and related semiologies may serve as clinical "red flags" for increased neurodevelopmental comorbidity severity, regardless of reported peak seizure frequency.